Diseases, Conditions, Syndromes

Therapy proves effective in subgroup of COPD patients

An antibody treatment reduces the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant chronic obstructive pulmonary disease (COPD), according to the results of two large international ...

Medical research

Research links telomere length to emphysema risk

Telomeres, the body's own cellular clocks, may be a crucial factor underlying the development of emphysema, according to research from Johns Hopkins University.

Diseases, Conditions, Syndromes

Bacteria in the mouth linked to pulmonary fibrosis survival

Bacteria in the mouth may play a role in survival from idiopathic pulmonary fibrosis (IPF), finds a new study led by researchers from the University of Michigan and the University of Virginia.

Diseases, Conditions, Syndromes

One-way valves to treat severe emphysema

Investigators at the University of Alabama at Birmingham are investigating whether a one-way valve placed in the lungs of patients with severe emphysema will help improve lung function. It is one of several techniques being ...

Diseases, Conditions, Syndromes

At my hospital, over 95% of COVID-19 patients are unvaccinated

As an emergency medicine and critical care doctor at the University of Washington School of Medicine in Seattle, I've lost count of the number of COVID-19 surges since the U.S. pandemic began in Seattle in February 2020. ...

Immunology

Coarse particulate matter may increase asthma risk

Children exposed to coarse particulate matter may be more likely to develop asthma and to be treated in an ER or be hospitalized for the condition, according to new research published online in the American Thoracic Society's ...

page 8 from 40